2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P56] Poster Session 56　Gastrointestinal Cancer（Colorectal Cancer 2）

[P56-1] FOLFIRI plus ramucirumab versus FOLFIRI plus bevacizumab as second-line chemotherapy for metastatic colorectal cancer

○Mika Kitagawa, Takaya Simura, Heroyasu Iwasaki, Mamoru Tanaka, Hiromi Kataoka (Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password